About Avertix
Avertix is a company based in Eatontown (United States) founded in 2001 by David Fischell. Avertix has raised $22.36 million across 6 funding rounds from investors including HHS. The company has 31 employees as of December 31, 2022. Avertix operates in a competitive market with competitors including iRhythm Tech, AliveCor, Imperative Care, Endotronix and Biotricity, among others.
- Headquarter Eatontown, United States
- Employees 31 as on 31 Dec, 2022
- Founders David Fischell
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Angel Medical Systems, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$22.36 M (USD)
in 6 rounds
-
Latest Funding Round
$1.01 M (USD), Series B
Sep 10, 2025
- Investors
-
Employee Count
31
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Avertix
Avertix has successfully raised a total of $22.36M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $1.01 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Avertix
Avertix has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Avertix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Avertix
Investment portfolio details for Avertix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Avertix
Detailed financials for Avertix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Avertix Comparisons
Peer comparison for Avertix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Avertix
Avertix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iRhythm Tech, AliveCor, Imperative Care, Endotronix and Biotricity, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
|
|
| Locked | Locked | Locked |
Cardiac monitoring devices and applications are provided for heart health.
|
|
| Locked | Locked | Locked |
Access catheters for neurovascular stroke treatment are provided.
|
|
| Locked | Locked | Locked |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| Locked | Locked | Locked |
Developer of medical remote monitoring solutions that help prevent and manage chronic diseases
|
|
| Locked | Locked | Locked |
AI-based EGC data capture and analysis platform
|
Detailed competitors of Avertix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Avertix
Complete news archive for Avertix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Avertix
Avertix was founded in 2001 and raised its 1st funding round 8 years after it was founded.
Avertix is headquartered in Eatontown, United States. It is registered at Eatontown, New Jersey, United States.
Timothy P Moran is the current CEO of Avertix.
Avertix is a funded company, having raised a total of $22.36M across 6 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Avertix is 31.
Avertix was founded in 2001 and is headquartered in Eatontown, United States. The company operates in the medical device sector, focusing on cardiology solutions. An implantable patient alerting system, known as the Guardian System, is developed to detect and warn about Acute Coronary Syndrome, including silent heart attacks. Patients are notified to seek medical attention through this technology.
Avertix's top competitors include AliveCor, iRhythm Tech and Endotronix.
Avertix has 1 investor. Key investors include HHS.